Results 301 to 310 of about 410,939 (360)

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

Missing cell types in single-cell references impact deconvolution of bulk data but are detectable. [PDF]

open access: yesGenome Biol
Ivich A   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy